Conducive policies are key for sustainable growth of pharmaceutical industry: PPMA Chief

Pakistan (Muhammad Yasir)

Conducive policies, fair pricing mechanisms, and investment in
research and development are crucial for the growth of the
pharmaceutical sector to meet domestic demand and a sustainable
increase in exports to different countries.

This was stated by the Chairman Pakistan Pharmaceutical Manufacturers
Association (PPMA) Mian Khalid Misbah ur Rehman while inaugurating the
20th Pharma Asia Exhibition and Conference organized by Ecommerce
Gateway Pakistan.

Speaking as a chief guest, he said the continuation of policies is
essential to protect the life-saving sector, which continued to grow
its productivity despite various challenges and the high cost of doing

He urged the pharmaceutical companies to bring efficiency in their
systems to offset the issue of high inflation, Rupee devaluation, high
packaging cost, etc.

He further said that pharmaceutical companies should focus on human
resources to sustain their business growth effectively.

PPMA added that the pharmaceutical companies in Pakistan produce
medicine at an international standard; hence, they can explore exports
in different countries to bring foreign exchange to the country.

The event hosted various seminars on the issues of pharmaceutical
industries which was addressed by Chairman PPMA South, President & CEO
of Medisure Laboratories, Sheikh Kaiser Waheed, Managing Director of
Sante (Pvt.) Ltd., Mr. Tauqeer ul Haq, Managing Director & CEO Martin
Dow, Mr. Javed Ghulam Mohammad, President Ecommerce Gateway, Dr.
Khursheed Nizam and Vice President Pharma Asia, Mr. Farhan Anis.

Pakistan’s pharmaceutical industry is a significant contributor to the
economy, with an estimated value of  $3.2 billion and a growth rate of
around 15% annually. The industry comprises over 700 manufacturing
units and employs a large workforce. It primarily focuses on generic
drugs, catering to a vast domestic market and exporting to over 60
countries. The industry holds immense potential for further growth and
expansion, but it must address challenges such as improving
infrastructure, enhancing research and development capabilities, and
strengthening intellectual property rights protection.

With 650 stalls, the exhibition promises an extensive showcase of
cutting-edge products, services, and innovations. This year’s event
boasts participation from more than 160 international representatives
from China, Turkey, Vietnam, UK, Germany and Malaysia, which further
solidifies Pharma Asia’s status as a globally recognized platform for
the pharmaceutical industry.

Farhan Anis- Vice President of Ecommerce Gateway Pakistan stated that,
“It is matter of pride for us to organize these international events
here in Pakistan. This event will be the biggest interactive platform
for the pharmaceutical industry to expand their outreach and customer
engagement. Companies belonging to the pharma sectors of the country
can take great advantage of the attentive and receptive target
audience to inspire and create new ventures.